179 related articles for article (PubMed ID: 38308969)
1. The role of microbial metabolites in endocrine tumorigenesis: From the mechanistic insights to potential therapeutic biomarkers.
Zhang Y; Tang N; Zhou H; Zhu Y
Biomed Pharmacother; 2024 Mar; 172():116218. PubMed ID: 38308969
[TBL] [Abstract][Full Text] [Related]
2. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
3. Microbial metabolites are involved in tumorigenesis and development by regulating immune responses.
Liu J; Tian R; Sun C; Guo Y; Dong L; Li Y; Song X
Front Immunol; 2023; 14():1290414. PubMed ID: 38169949
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?
Dong Y; Zhang K; Wei J; Ding Y; Wang X; Hou H; Wu J; Liu T; Wang B; Cao H
Front Immunol; 2023; 14():1158200. PubMed ID: 37122756
[TBL] [Abstract][Full Text] [Related]
5. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
7. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.
Gao J; Xu K; Liu H; Liu G; Bai M; Peng C; Li T; Yin Y
Front Cell Infect Microbiol; 2018; 8():13. PubMed ID: 29468141
[TBL] [Abstract][Full Text] [Related]
9. Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease.
Dongoran RA; Tu FC; Liu CH
Tzu Chi Med J; 2023; 35(4):290-299. PubMed ID: 38035056
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Insights into the Anti-Proliferative Action of Gut Microbial Metabolites against Breast Adenocarcinoma Cells.
Jaye K; Alsherbiny MA; Chang D; Li CG; Bhuyan DJ
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894734
[TBL] [Abstract][Full Text] [Related]
11. The role of short-chain fatty acids (SCFAs) in regulating stress responses, eating behavior, and nutritional state in anorexia nervosa: protocol for a randomized controlled trial.
Quagebeur R; Dalile B; Raes J; Van Oudenhove L; Verbeke K; Vrieze E
J Eat Disord; 2023 Oct; 11(1):191. PubMed ID: 37884972
[TBL] [Abstract][Full Text] [Related]
12. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
[TBL] [Abstract][Full Text] [Related]
13. Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer.
Chen Y; Chen YX
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439208
[TBL] [Abstract][Full Text] [Related]
14. The interplay between microbial metabolites and macrophages in cardiovascular diseases: A comprehensive review.
Yang Y; Karampoor S; Mirzaei R; Borozdkin L; Zhu P
Int Immunopharmacol; 2023 Aug; 121():110546. PubMed ID: 37364331
[TBL] [Abstract][Full Text] [Related]
15. Role of microbiota-derived short-chain fatty acids in nervous system disorders.
Mirzaei R; Bouzari B; Hosseini-Fard SR; Mazaheri M; Ahmadyousefi Y; Abdi M; Jalalifar S; Karimitabar Z; Teimoori A; Keyvani H; Zamani F; Yousefimashouf R; Karampoor S
Biomed Pharmacother; 2021 Jul; 139():111661. PubMed ID: 34243604
[TBL] [Abstract][Full Text] [Related]
16. Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls.
Olsson A; Gustavsen S; Nguyen TD; Nyman M; Langkilde AR; Hansen TH; Sellebjerg F; Oturai AB; Bach Søndergaard H
Front Immunol; 2021; 12():661493. PubMed ID: 34025661
[TBL] [Abstract][Full Text] [Related]
17. Microbiota metabolites in the female reproductive system: Focused on the short-chain fatty acids.
Mirzaei R; Kavyani B; Nabizadeh E; Kadkhoda H; Asghari Ozma M; Abdi M
Heliyon; 2023 Mar; 9(3):e14562. PubMed ID: 36967966
[TBL] [Abstract][Full Text] [Related]
18. The bridge of the gut-joint axis: Gut microbial metabolites in rheumatoid arthritis.
Xu X; Wang M; Wang Z; Chen Q; Chen X; Xu Y; Dai M; Wu B; Li Y
Front Immunol; 2022; 13():1007610. PubMed ID: 36275747
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular Delivery of Gut-derived Microbial Metabolites in Freely Moving Mice.
Liou CW; Yao TH; Wu WL
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35723471
[TBL] [Abstract][Full Text] [Related]
20. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]